Inspire Medical Systems (INSP) Competitors $80.84 +0.80 (+0.99%) As of 11:26 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INSP vs. PEN, STVN, GKOS, IRTC, BLCO, TMDX, SLNO, NVST, LIVN, and WRBYShould you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. Inspire Medical Systems vs. Its Competitors Penumbra Stevanato Group Glaukos iRhythm Technologies Bausch + Lomb TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Penumbra (NYSE:PEN) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Do analysts rate PEN or INSP? Penumbra currently has a consensus target price of $302.93, suggesting a potential upside of 11.15%. Inspire Medical Systems has a consensus target price of $164.50, suggesting a potential upside of 99.97%. Given Inspire Medical Systems' higher probable upside, analysts plainly believe Inspire Medical Systems is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88Inspire Medical Systems 0 Sell rating(s) 6 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.57 Is PEN or INSP more profitable? Penumbra has a net margin of 11.54% compared to Inspire Medical Systems' net margin of 6.17%. Penumbra's return on equity of 11.55% beat Inspire Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Penumbra11.54% 11.55% 8.76% Inspire Medical Systems 6.17%10.38%8.93% Which has preferable valuation & earnings, PEN or INSP? Inspire Medical Systems has lower revenue, but higher earnings than Penumbra. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPenumbra$1.28B8.30$14.01M$3.7672.49Inspire Medical Systems$802.80M3.03$53.51M$1.7347.55 Does the media prefer PEN or INSP? In the previous week, Inspire Medical Systems had 4 more articles in the media than Penumbra. MarketBeat recorded 16 mentions for Inspire Medical Systems and 12 mentions for Penumbra. Penumbra's average media sentiment score of 1.43 beat Inspire Medical Systems' score of 1.26 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 11 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, PEN or INSP? Penumbra has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Do insiders and institutionals hold more shares of PEN or INSP? 88.9% of Penumbra shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.2% of Penumbra shares are owned by company insiders. Comparatively, 2.3% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryPenumbra beats Inspire Medical Systems on 11 of the 17 factors compared between the two stocks. Get Inspire Medical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INSP vs. The Competition Export to ExcelMetricInspire Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$2.43B$2.17B$5.76B$21.55BDividend YieldN/AN/A5.73%3.49%P/E Ratio47.5338.3575.4429.81Price / Sales3.0310.26457.8354.22Price / Cash46.8558.5825.8118.13Price / Book3.5811.7713.234.66Net Income$53.51M-$63.67M$3.29B$999.94M7 Day Performance-1.49%-2.08%0.93%0.98%1 Month Performance-6.17%2.82%5.14%4.75%1 Year Performance-59.67%128.77%74.06%16.89% Inspire Medical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INSPInspire Medical Systems4.9002 of 5 stars$80.85+1.0%$164.50+103.5%-60.6%$2.39B$802.80M46.731,246Positive NewsPENPenumbra4.6298 of 5 stars$272.96+0.5%$300.47+10.1%+46.3%$10.65B$1.19B72.604,500Positive NewsSTVNStevanato GroupN/A€23.14-1.4%N/A+37.2%€7.01B€1.19B42.855,521Gap UpGKOSGlaukos4.6475 of 5 stars$95.86-0.7%$127.42+32.9%-34.5%$5.50B$383.48M-58.10780Positive NewsIRTCiRhythm Technologies1.2078 of 5 stars$169.98-0.9%$163.82-3.6%+134.7%$5.46B$591.84M-58.012,000Positive NewsBLCOBausch + Lomb2.076 of 5 stars$14.63+0.6%$15.56+6.3%-2.2%$5.18B$4.79B-18.7613,500Positive NewsTMDXTransMedics Group2.4121 of 5 stars$114.96-1.5%$123.00+7.0%-24.3%$3.92B$531.29M59.57210SLNOSoleno Therapeutics4.444 of 5 stars$67.67-1.1%$115.09+70.1%+1.5%$3.60BN/A-16.3530Positive NewsShort Interest ↑Analyst RevisionNVSTEnvista3.831 of 5 stars$21.15-0.5%$20.92-1.0%+8.4%$3.51B$2.55B66.0812,700Positive NewsLIVNLivaNova2.9272 of 5 stars$56.37+1.7%$59.71+5.9%+15.8%$3.08B$1.31B-14.492,900Positive NewsWRBYWarby Parker1.417 of 5 stars$26.16-0.3%$24.06-8.0%+82.6%$2.75B$821.35M-373.723,030Analyst Upgrade Related Companies and Tools Related Companies Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives iRhythm Technologies Alternatives Bausch + Lomb Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives Envista Alternatives LivaNova Alternatives Warby Parker Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INSP) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
